ISOFLURANE USP LIQUID
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
23-05-2018
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
ISOFLURANE
Inapatikana kutoka:
FRESENIUS KABI CANADA LTD
ATC kanuni:
N01AB06
INN (Jina la Kimataifa):
ISOFLURANE
Kipimo:
99.9%
Dawa fomu:
LIQUID
Tungo:
ISOFLURANE 99.9%
Njia ya uendeshaji:
INHALATION
Vitengo katika mfuko:
100/250ML
Dawa ya aina:
Prescription
Eneo la matibabu:
INHALATION ANESTHETICS
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0114368001; AHFS:
Idhini hali ya:
APPROVED
Idhini ya tarehe:
2006-10-05
Tabia za bidhaa
PRODUCT
MONOGRAPH
PR
ISOFLURANE USP
(Isoflurane, 99.9%)
Inhalation Anesthetic
FRESENIUS KABI CANADA LTD.
165 Galaxy Blvd, Suite 100
Toronto, ON M9W 0C8
Date of Revision:
May 23, 2018
Control No.: 215732
Isoflurane USP - Product Monograph_ _
Page 2 of 26
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT
INFORMATION.................................................................................
3
INDICATIONS AND CLINICAL USE
......................................................................................
3
CONTRAINDICATIONS
............................................................................................................
3
WARNINGS AND PRECAUTIONS
..........................................................................................
4
ADVERSE REACTIONS
............................................................................................................
8
DRUG INTERACTIONS
..........................................................................................................
11
DOSAGE AND ADMINISTRATION
......................................................................................
13
OVERDOSAGE
.........................................................................................................................
15
STORAGE AND STABILITY
..................................................................................................
17
DOSAGE FORMS, COMPOSITION AND PACKAGING
..................................................... 17
PART II: SCIENTIFIC INFORMATION
...............................................................................18
PHARMACEUTICAL INFORMATION
..................................................................................
18
DETAILED PHARMACOLOGY
.............................................................................................
19
TOXICOLOGY
.................................................................................................................
Soma hati kamili
